As a sole-contributor scientist, you will bring deep expertise in genetic, biochemical and molecular biology assays to develop and execute phase-appropriate approaches supporting pharmacokinetic/pharmacodynamic (PK/PD) analysis. You will work across technologies including genomic DNA and RNA isolation, qPCR, ddPCR, RNA sequencing, MSD, ELISA and immunoblotting, while establishing robust mRNA-based bioanalytical capabilities internally and with external partners.
This is an opportunity to operate at the intersection of translational science, clinical bioanalysis and emerging technology. Alongside hands-on scientific and regulatory responsibilities, you will have opportunities to get close to Generative AI and digital tools that can support scientific workflows, knowledge synthesis and data-driven ways of working across Moderna.